DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Quibron-T (Theophylline, Anhydrous) - Summary

 

-- advertisement --

QUIBRON-T SUMMARY

QUIBRON®-T
(Theophylline Tablets USP)
ACCUDOSE® Tablets
IMMEDIATE-RELEASE BRONCHODILATOR

Theophylline is structurally classified as a methylxanthine.

Quibron®-T is available as tablets intended for oral administration, containing 300 mg of anhydrous theophylline per tablet. Quibron®-T is an oral bronchodilator in an immediate-release formulation in the ACCUDOSE® Tablet design. With functional trisects and bisects, Quibron®-T Tablets can be accurately divided into 100-, 150-, and 200-mg segments to provide a variety of dosing increments, as required.

Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

QUIBRON-T NEWS HIGHLIGHTS

Media Articles Related to Quibron-T (Theophylline)

Web-Based Asthma Monitoring Enables Physicians To Monitor, Control Asthma Remotely
Source: Respiratory / Asthma News From Medical News Today [2008.08.25]

Lung Association Urges Back-to-School Asthma Checklist
Source: MedicineNet Allergy Specialty [2008.08.25]

Lung Association Urges Back-to-School Asthma Checklist (HealthDay)
Source: Y! Health Asthma News [2008.08.23]

Study Looks At Literacy Intervention To Improve Asthma-Related Health Outcomes Among Minority Youth
Source: Respiratory / Asthma News From Medical News Today [2008.08.21]

New Study Finds Parents Embrace Alternative Treatments For Children's Asthma
Source: Respiratory / Asthma News From Medical News Today [2008.08.18]

more>>

Published Studies Related to Quibron-T (Theophylline)

A Randomized Controlled Trial of Theophylline Versus CO(2) Inhalation for Treating Apnea of Prematurity. [2008.06.03]

Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD. [2008]

Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma--results from the ALA-ACRC low-dose theophylline trial. [2007.10]

The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. [2007.09]

In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. [2007.08.16]

more>>

Clinical Trials Related to Quibron-T (Theophylline)

Rosiglitazone Versus Theophylline in Asthmatic Smokers [Completed]

All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab and Theophylline [Recruiting]

Theophylline in Chronic Obstructive Pulmonary Disease [Recruiting]

Theophylline in Treating Cancer Patients With Shortness of Breath [Active, not recruiting]

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia [Completed]

more>>

Page last updated: 2008-08-25

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008